ACC 2024: U-Mich Experts for Comment on Late-Breaking Trials

ACC 2024: U-Mich Experts for Comment on Late-Breaking Trials, Featured Research

Hi there,
Tomorrow begins the ACC 73rd Annual Scientific Sessions in Atlanta. Experts from the University of Michigan Health Frankel Cardiovascular Center have

Related Keywords

United States , American , Brahmajee Nallamothu , Eric Cantey , Marvinm Kirsh , Toddm Koelling , Stanleyj Chetcuti , Kent Brummel , Scott Hummel , Gorav Ailawadi , John Bisognano , Ericj Topol , Ericj Brandt , Structural Heart Program , Heart Transplantation Management Program , National Heart , Um Health Frankel Cardiovascular Center , Veterans Health Administration , Um Precision Health Initiative , Um Frankel Cardiovascular Center , University Of Michigan Health Frankel Cardiovascular Center , School Of Public Health , Um Health Frankel Cardiovascular Center Available Experts , Stevo Julius Research Professor Of Cardiovascular Medicine , Gum Health , Va Ann Arbor Health Care , Frankel Cardiovascular Center , Agency For Healthcare Research , Um School Of Public Health , College Of Engineering , Professor Of Health Management , American Heart Association , Annual Scientific Sessions , Michigan Health Frankel Cardiovascular Center , Cardiovascular Center , Kahn Pavilion , Cardiac Surgery , Um Medical School , Patients With Small Aortic Annuli , Primary Outcomes From , Randomized Smart Trial , Um Medical , After Acute Myocardial Infarction , Combination With , Standard Of Care Antihypertensive , Primary Results From , Apolipoproteina I , Cardiovascular Outcomes , Patients With Acute Myocardial Infarction , Apoai Event Reducing , Ischemic Syndromes , Primary Trial Results , Edetate Disodium Based Chelation Infusions , Cardiovascular Events , With Diabetes , Um Health Frankel Cardiovascular , Randomized Clinical Non Inferiority Trial , Evaluate Lerodalcibep Long Term Efficacy , Patients With , High Risk , For Cardiovascular Disease , Stable Lipid Lowering Therapy , Results From The Huddle Study , Results Of The Danger Shock Trial , Collegiate Professor , Cardiovascular Medicine , Albion Walter Hewlett Professor , Internal Medicine , Health Management , Um School , Heart Your , Preserved Left Ventricular Ejection Fraction , Harbor Health , National Institute , Blood Institutes , Healthcare Research , American Heart , Randomized Placebo Procedure Controlled Trial , Principal Results From The , Heart Failure , Selective Aldose Reductase Inhibitor , Diabetic Cardiomyopathy , Primary Results , Stevo Julius Research Professor , Medical School , Cardiovascular Quality , Newswise , Cc 2024 American College Of Cardiology Acc , Ichigan Medicine University Of Michigan ,

© 2025 Vimarsana